TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn’s disease.
Michigan Medicine researchers confirmed this finding using prospective data.
The resulting paper, “Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn’s disease: Post-hoc analysis of the RISK study,” appeared in Gut.
A previous retrospective study from the same team had established a link between early treatment and reduced likelihood of perianal fistulas.
That research, however, ...











